Skip to search formSkip to main contentSkip to account menu

Combivir

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Antiretroviral (ARV) drugs are given in combination to treat the human immunodeficiency virus (HIV) infection and to prolong the… 
2017
2017
Highly Cited
2012
Highly Cited
2012
Background:MERIT was a randomized trial comparing maraviroc (MVC) + Combivir versus efavirenz (EFV) + Combivir in drug-naive… 
2011
2011
Abstract Adherence may be facilitated by reducing perceptual and practical barriers to antiretroviral therapy (ART). Practical… 
Highly Cited
2009
Highly Cited
2009
Neil Martinson and colleagues report a randomized trial of adding short-course zidovudine+lamivudine to reduce drug resistance… 
2007
2007
Combivir is a fixed dose combination tablet of two antiretroviral drugs; zidovudine and lamivudine, used in the treatment of HIV… 
Highly Cited
2006
Highly Cited
2006
To compare the lipid and metabolic effects, efficacy, and safety of twice‐daily regimens of Trizivir® (abacavir 300 mg/lamivudine… 
Highly Cited
2004
Highly Cited
2004
Objective: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial… 
Highly Cited
2003
Highly Cited
2003
Objective: HIV‐1 protease inhibitors (versus no protease inhibitors) and stavudine (versus zidovudine) are independently… 
Highly Cited
2001
Highly Cited
2001
Background Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a valid alternative to protease inhibitor…